In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
WASHINGTON: Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and ...
A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating ...